|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Stock compensation | ||||
| Depreciation | ||||
| Amortization | ||||
| Non-cash lease expense | ||||
| Write off of inventory | ||||
| Gain on sale of short-term investments | ||||
| Extinguishment of debt - note payable | ||||
| Return on investment in Joint Venture | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Accounts receivable - related party | ||||
| Prepaid assets | ||||
| Inventory | ||||
| Accounts payable - related party | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Accrued expenses - related party | ||||
| Lease liability | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Sale of short-term investments | ||||
| Purchase of short-term investments | ||||
| Investment in Equity Method Investment | ||||
| Purchase of patents | ||||
| Purchase of trademarks | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Sale of common stock for cash, net of financing fees | ||||
| Payments on notes payable - officer | ||||
| Proceeds from ATM, net of fees | ||||
| Net cash provided by financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents - beginning of year | ||||
| Cash and cash equivalents - end of year | ||||
| Non-cash investing and financing activities: | ||||
| Unrealized loss on short-term investments | ||||
| Unrealized gain (loss) on short-term investments | ||||
Loading...
